Identive expands implementation of HIRSCH access to include San Diego International Airport's redesigned Terminal 2, known as the "Green Build."
Deals
Akorn says it will purchase rival for USD 640 million
Generic eye drug manufacturer Akorn said that it would be buying Hi-Tech Pharmacal Co Inc in a deal worth USD 640 million.
Total agrees on purchase of Chevron's Egyptian retain network
French oil and gas company Total said that it would be buying the retail network of US-based Chevron in Egypt.
AstraZeneca announces another M&A with Amplimmune
AstraZeneca has been looking at another acquisition deal even after spending almost USD1 billion in acquisitions earlier this year.
WaterSmart Software raises USD 4.5 million in Series A round
WaterSmart Software announced the closing of its Series A funding with USD 4.5 million led by The Westly Group.
Latest News
Vestagen Technical Textiles was able to raise USD 8.25 million for the commercial launch of its scrub uniforms.
A source told Reuters that Arrow LNG would consider building its LNG plant on a rival's site. Arrow LNG, the Australian joint venture firm of Royal Dutch Shell and PetroChina, would consider building its liquefied natural gas plant on Origin Energy's site.
Lloyds Banking Group agreed on a sale of its loan asset portfolio from its BOS International Australia unit to Bain Capital's Sankaty Advisors.
Indian telecommunications firm Reliance Communications said that it had been talking with partners for a stake sale of one of its units.
Indonesia gathered IDR 12 trillion in its most recent bond offering, beating an initial target of IDR 8 trillion.
Telekom Austria plans to raise EUR500 million to buy new frequencies and acquire companies. With the objective of purchasing new frequencies in a September auction and acquiring companies, Telekom Austria has planned to raise EUR500 million in fresh capital, the Der Standard reported.
Italian fashion company Trussardi said it would sell minority shares in the future if it needed to. Trussardi might offer a minority stake in the future to interested parties if it needed to.
London-focused real estate agent Foxtons said it would be selling new shares and company shares in its planned IPO to raise GBP 55 million.
As Amgen Inc's acquisition of Onyx Pharmeceuticals Inc comes to a close, Amgen Chief Executive Officer Robert Bradway is lauded for being a great dealmaker.
